Skip to main content
Wolters Kluwer - PMC COVID-19 Collection logoLink to Wolters Kluwer - PMC COVID-19 Collection
editorial
. 2022 Oct 27;48(3):264–265. doi: 10.1097/RLU.0000000000004470

Ipsilateral Upper-Limb Lymphedema After COVID-19 Vaccine Booster

Charlene Yu Lin Tang 1, Wei Ming Chua 1
PMCID: PMC9907355  PMID: 36302077

Abstract

Recent data suggest that protective immunity from COVID-19 vaccine may wane after a period, with booster doses becoming increasingly deployed in many countries. An 84-year-old woman presents with a 6-month history of left upper-limb swelling; the only history of note was an intramuscular Pfizer-BioNTech mRNA vaccine booster in the ipsilateral deltoid just 1 week before the onset of the swelling. Upper-extremity lymphoscintigraphy after the administration of 99mTc-nanocolloid into the interstitial space of the hands showed left upper-limb lymphatic dysfunction.

Key Words: COVID-19, lymphedema, booster, nanocolloid


FIGURE 1.

FIGURE 1

Grayscale ultrasound image showing thickening of the subcutaneous tissue layer. An 84-year-old woman presents with a 6-month history of left upper-limb swelling; the only history of note was an intramuscular Pfizer-BioNTech mRNA vaccine booster1 in the ipsilateral deltoid just 1 week before the onset of the swelling. A CT thorax, abdomen, and pelvis done as part of surveillance for her resected gastric cancer were unremarkable.2 An ultrasound deep venous thrombosis of the left upper limb shows thickening of the subcutaneous tissue layer but was otherwise unremarkable.

FIGURE 2.

FIGURE 2

An 84-year-old woman presents with a 6-month history of left upper-limb swelling. Upper-extremity lymphoscintigraphy after administration of 99mTc-nanocolloid3,4 into the interstitial space of the hands. Shown are the images 1 hour after injection, images 2 hours after injection, and images 4 hours after injection. Appearance of marked dermal backflow in the left upper limb, with absence of discrete lymphatic channels and absence of radionuclide uptake in expected location of left axillary lymph nodes, suggestive of left upper-extremity lymphatic dysfunction. Lymphadenopathy post–COVID-19 vaccination is now well established and postulated to be related to the transient inflammation from immune system activation.57 There have also been rare case reports of lower-limb lymphedema after COVID-19 vaccination.8 Lymphedema occurs as a result of an imbalance between the lymphatic load and the transport capacity of the lymphatic system.8 In this patient, the vaccination may have resulted in damage to the lymphatic vessels or lymph nodes with a decrease in the numbers or obstruction of lymph channels.

Footnotes

Conflicts of interest and sources of funding: none declared.

REFERENCES

  • 1.Feikin DR Higdon MM Abu-Raddad LJ, et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022;399:924–944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Aimo C Mariotti EB Corrà A, et al. Lymphedema of the arm after COVID-19 vaccination in a patient with hidden breast cancer and paraneoplastic dermatomyositis. Vaccines (Basel). 2022;10:1219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Weissleder H, Weissleder R. Lymphedema: evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients. Radiology. 1988;167:729–735. [DOI] [PubMed] [Google Scholar]
  • 4.Villa G Campisi CC Ryan M, et al. Procedural recommendations for lymphoscintigraphy in the diagnosis of peripheral lymphedema: the Genoa protocol. Nucl Med Mol Imaging. 2019;53:47–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Menni C Klaser K May A, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID symptom study app in the UK: a prospective observational study. Lancet Infect Dis. 2021;21:939–949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Ahmed N Muzaffar S Binns C, et al. COVID-19 vaccination manifesting as incidental lymph nodal uptake on 18F-FDG PET/CT. Clin Nucl Med. 2021;46:435–436. [DOI] [PubMed] [Google Scholar]
  • 7.Ha SM Chu AJ Lee J, et al. US evaluation of axillary lymphadenopathy following COVID-19 vaccination: a prospective longitudinal study. Radiology. 2022;305:46–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Chung JH Sohn SM Yoo HJ, et al. Transient lower extremity lymphedema following COVID-19 vaccination: a case report. Medicine (Baltimore). 2021;100:e28092. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Nuclear Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES